Across the health care system, administrators, clinicians and researchers all face the challenge of justifying their decisions with particular emphasis on cost effectiveness. Economic evaluation of health interventions provides a powerful tool to address these questions.

SPHA 531 Economic Evaluation (MHA Year Two) teaches students to apply a specific cost-effectiveness analysis to approach resource allocation problems specific to health interventions, ie. Do they represent good choices from a value for money perspective? The course teaches the concept of maximizing the health benefits accruing from finite health care budgets. Economic evaluation is one specialty area within the larger domain of health economics.

Read about other  MHA courses our students are taking

Instructor Profile

Adam Raymakers

Adam Raymakers is a Research Fellow with the Program on Regulation, Therapeutics, and Law (PORTAL)
at Harvard Medical School and Brigham & Women’s Hospital. He also serves on the pan-Canadian
Oncology Drug Review, Expert Review Committee with the Canadian Drug Agency. Adam also serves on
the editorial board of the journals Health Policy and Technology and Applied Health Economics and
Health Policy. He was formerly a post-doctoral fellow with BC Cancer and Simon Fraser where he was
awarded a Michael Smith Foundation for Health Research post-doctoral training award. He completed
his PhD at the University of British Columbia, his master’s degree at Erasmus University Rotterdam, and
his undergraduate degree at Dalhousie University.